In an interview with CNBC-TV18, Alok Saxena, Director (International), Elder Pharmaceuticals spoke about the performance of the company. The company is expecting its domestic formulation business to report growth of 20-25% ahead.
first published: May 10, 2011 04:31 pm
A collection of the most-viewed Moneycontrol videos.
Live: Sensex, Nifty fall 1% amidst broad-based selloff | Closing Bell
Live: Can Nifty reclaim record levels as investors await FOMC decision this week? | Opening Bell
Why This Tenant Says Bandra Is Better Than California | The Tenant
Nifty Clocks Triple-Digit Gains After RBI Rate Cut But Logs Losses For The Week| Closing Bell Live
